Literature DB >> 12708702

Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.

Anita Girdhar1, J K Chakma, B K Girdhar.   

Abstract

A pilot study has been undertaken to compare the efficacy of small dose pulsed betamethasone therapy with need based oral steroids in chronic recurrent erythema nodosum leprosum (ENL) patients. Though this mode of therapy was well tolerated, no advantage with intermittent steroid administration was observed. This could have been on account of small dose of steroid given monthly. Treatment of chronic recurrent erythema nodosum leprosum (ENL) patients continues to be unsatisfactory, particularly, because of nonavailability of thalidomide. Though corticosteroids are effective in suppressing all the manifestations and even restoring partially or fully the functional impairment, their side effects and dependence are equally troublesome. Based on (a) the reported efficacy and safety of intermittent use of corticosteroids in several immune complex mediated disorders (Cathcart et al 1976, Kimberly et al 1979), Liebling et al 1981 and Pasricha & Gupta 1984) and (b) ENL (type II) reactions having similar pathology, a pilot study has been undertaken to see the efficacy and the tolerance of pulsed steroids in chronic ENL patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12708702

Source DB:  PubMed          Journal:  Indian J Lepr        ISSN: 0254-9395


  4 in total

1.  ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.

Authors:  Stephen L Walker; Marivic Balagon; Joydeepa Darlong; Shimelis N Doni; Deanna A Hagge; Vikas Halwai; Annamma John; Saba M Lambert; Armi Maghanoy; Jose A C Nery; Kapil D Neupane; Peter G Nicholls; Vivek V Pai; Pawan Parajuli; Anna M Sales; Euzenir Sarno; Mahesh Shah; Digafe Tsegaye; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2015-09-09

2.  Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.

Authors:  Brahmaiah Upputuri; Michael Sukumar Pallapati; Patrick Tarwater; Aparna Srikantam
Journal:  PLoS Negl Trop Dis       Date:  2020-10-09

3.  A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale.

Authors:  Stephen L Walker; Anna M Sales; C Ruth Butlin; Mahesh Shah; Armi Maghanoy; Saba M Lambert; Joydeepa Darlong; Benjamin Jewel Rozario; Vivek V Pai; Marivic Balagon; Shimelis N Doni; Deanna A Hagge; José A C Nery; Kapil D Neupane; Suwash Baral; Biliom A Sangma; Digafe T Alembo; Abeba M Yetaye; Belaynesh A Hassan; Mohammed B Shelemo; Peter G Nicholls; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2017-07-03

4.  Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.

Authors:  Barbara de Barros; Saba M Lambert; Mahesh Shah; Vivek V Pai; Joydeepa Darlong; Benjamin Jewel Rozario; Medhi Denisa Alinda; Anna M Sales; Shimelis Doni; Deanna A Hagge; Dilip Shrestha; M Yulianto Listiawan; Abeba M Yitaye; Jose A C Nery; Kapil D Neupane; Vivianne L A Dias; C Ruth Butlin; Peter G Nicholls; Diana Lockwood; Stephen L Walker
Journal:  BMJ Open       Date:  2020-11-17       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.